Rejuve Anti Aging Medical Spa in Rancho Santa Margarita
STEM CELL JOINT INJECTIONS
ELBOW PAIN
Regenerative medicine treatments may offer a superior alternative to elbow surgery.
Rediscover pain-free movement with Rejuve Anti Aging’s cutting-edge regenerative therapies. Our advanced trifecta joint injections—featuring PRP, Stem Cells, and Exosomes—offer a sophisticated, non-surgical solution for elbow pain and joint injuries.
By harnessing your body’s natural healing power, these innovative treatments stimulate tissue repair and regeneration, effectively addressing conditions such as arthritis, tendonitis, ligament strains, and golfer’s or tennis elbow. Unlike traditional methods that only mask pain, our regenerative solutions target the root cause, promoting long-term healing and improved function.
Whether you’re an athlete striving to stay active, dealing with chronic elbow discomfort, or simply looking to maintain peak mobility as you age, Rejuve’s regenerative therapies can help restore strength and flexibility. Experience a revitalized, pain-free life and potentially delay—or even avoid—costly and invasive surgery.
Avoid the risks and lengthy recovery of traditional elbow procedures. Rejuve Anti Aging offers ultrasound-guided stem cell injections, a precise, image-assisted technique using your own Mesenchymal Stem Cells to repair damaged elbow tissues. This groundbreaking treatment fosters natural healing and optimal function, providing a safer and more effective alternative to surgery.
Tennis & Golf Elbow - Tommy John Surgery
WANT THE SCIENCE & DETAILS?
DOWNLOAD MESENCHYMAL STEM CELLS INFORMATION KIT
PROVEN RESULTS
Stem cell therapy: clinically proven to reduce joint pain and improve mobility.
NATURAL & SAFE
Leveraging the body’s own processes combined with PRP, Stem Cells and Exosomes
SIMPLE 30 MIN PROCEDURE
Ultrasound guided, highly accurate joint injections without anesthesia or downtime.
100% GUARANTEE OF ELBOW PAIN REDUCTION!
Details Available During The Consultation
Clinical Studies of Stem Cells and Elbow Injuries
Over the past decade, interest in mesenchymal stem cell (MSC) therapy for elbow injuries has skyrocketed, with research and clinical trials ramping up to refine this cutting-edge treatment.
Recent breakthroughs go beyond MSCs’ ability to transform into different cell types—scientists are now diving into their powerful roles in paracrine signaling and immunomodulation. This shift in focus is unlocking new possibilities for targeted, next-level regenerative treatments.
With more clinical trials in motion, the push to bring MSC therapy from the lab to real-world applications is stronger than ever. The goal? To deliver real relief for patients battling chronic pain, tendon injuries, and joint degeneration.
"At 24 weeks, patients reported a 71.5% improvement in pain scores"
Journal of Shoulder Elbow Surg
Tennis Elbow: A Double-Blind, Randomized Controlled Trial of 230 Patients
"Effect of mesenchymal stem cell therapy in the treatment of elbow tendinopathy"
BMJ Case Rep
Repeat imaging showed successful regeneration of tendon-like tissue
"Mesenchymal stem cells vs Corticosteroid injections for Tennis Elbow. Stem cells were most effective for improving pain and function"
Orthopedic Journal of Sports Medicine
End Elbow Pain!
Have you been told that the only way to relieve your elbow pain is through steroid injections or invasive surgery?
Studies indicate that common elbow surgeries, such as tendon debridement procedures, often provide no greater benefit than placebo treatments. This raises concerns about their actual effectiveness in reducing pain and restoring function.
While surgical intervention may be necessary in severe cases, elbow surgeries are highly invasive and come with significant risks. The lengthy rehabilitation process and potential for scar tissue formation or further joint degeneration can sometimes lead to long-term complications. These factors highlight the need to carefully evaluate surgical options, especially when effective regenerative therapies offer a less invasive alternative for healing and pain relief.
Stem Cell Therapy Could Be The Exact Non-Surgical Alternative You’ve Been Waiting For!
Reclaim your active lifestyle. Rejuve Anti-Aging offers non-surgical solutions to get you back to the activities you love.
The fear is real: a sudden, sharp pain, your elbow giving out, a loss of grip. The uncertainty of every movement keeps you on edge, making you second-guess simple tasks. Imagine struggling to lift a bag of groceries, hesitating to play catch with your child, or avoiding activities you once loved because of the nagging pain and instability in your elbow.
For months, the stiffness, weakness, and discomfort have held you back, making even routine motions feel risky. The thought of invasive surgery looms over you, with its long recovery times and unpredictable outcomes. But what if there was another way?
At Rejuve Anti Aging, we understand the frustration and limitations that come with elbow pain and instability. That’s why we offer cutting-edge, non-surgical regenerative solutions designed to activate your body’s natural healing process. With advanced treatments like PRP, Stem Cells, and Exosomes, we help restore strength, stability, and function—so you can move freely and confidently without the fear of surgery. Let us guide you toward a future of pain-free movement and renewed vitality.
DO YOU HAVE SPECIFIC QUESTIONS ABOUT HOW STEM CELLS WORK?
ASK OUR SMART AI ASSISTANT
Outcomes For Stem Cell Elbow Procedures
COMMON ELBOW CONDITIONS TREATED WITH STEM CELL JOINT INJECTIONS AT REJUVE ANTI AGING
-
TENNIS ELBOW
Understanding Tennis Elbow: Causes, Treatments, and Advanced Regenerative Solutions
Lateral epicondylitis, commonly known as tennis elbow or elbow tendinitis, has traditionally been linked to repetitive overuse of the elbow, such as the motions involved in playing tennis. However, we now understand that this condition often develops in middle-aged individuals due to underlying nerve issues, such as a pinched nerve in the neck. Even in the absence of neck pain, nerve compression can lead to increased tightness in the forearm muscles, placing excessive strain on the tendons at the lateral epicondyle and ultimately causing tennis elbow.
The Limitations of Conventional Treatments
Conservative treatments—including rest, ice, heat, bracing, and physical therapy—can be effective for managing tennis elbow, but they require time and patience. For those who need a quicker recovery, such as athletes or laborers, surgery may seem like a logical solution. However, recent studies suggest otherwise. Research increasingly shows that common surgical procedures for tennis elbow often fail to provide reliable long-term results, especially for individuals over 40. Even in younger patients, success is not guaranteed, yet many remain unaware of these findings, perpetuating the misconception that surgery is the only viable option.
When traditional treatments prove ineffective, physicians may turn to steroid injections as a next step. However, research warns against this approach, as steroids can weaken tendon cells, worsen inflammation, break down cartilage, and even increase the risk of fractures. While they may offer temporary pain relief, they ultimately contribute to long-term damage.
A Regenerative Approach to Healing Tennis Elbow
For those seeking a safer, more effective alternative, regenerative medicine offers a promising solution. Studies have shown that stem cell therapy combined with platelet-rich plasma (PRP) injections can deliver significant long-term improvements for patients with tennis elbow. Unlike steroids, which degrade tissues over time, these biologic treatments work with your body’s natural healing processes to repair damaged tendons, reduce inflammation, and restore function.
At Rejuve, we specialize in cutting-edge regenerative therapies designed to address the root cause of tennis elbow, providing lasting relief without the risks of surgery or steroids. If you’re ready to regain strength, mobility, and confidence in your arm, our innovative treatments can help you get back to doing what you love—without compromise.
-
GOLFER'S ELBOW
Understanding Golfer’s Elbow: Causes, Treatments, and Advanced Regenerative Solutions
Medial epicondylitis, commonly known as golfer’s elbow or elbow tendinitis, has traditionally been linked to repetitive overuse of the forearm muscles, such as the motions involved in swinging a golf club. However, this condition frequently develops in middle-aged individuals due to underlying nerve issues, such as a pinched nerve in the neck. Even without noticeable neck pain, nerve compression can lead to increased tightness in the forearm muscles, placing excessive strain on the tendons at the medial epicondyle and ultimately causing golfer’s elbow.
The Limitations of Conventional Treatments
Conservative treatments—including rest, ice, heat, bracing, and physical therapy—can be effective for managing golfer’s elbow, but they require time and patience. For individuals needing a faster recovery, such as athletes or manual laborers, surgery may seem like a logical solution. However, recent research suggests otherwise. Studies increasingly show that common surgical procedures for golfer’s elbow often fail to provide consistent long-term relief, particularly for individuals over 40. Even younger patients face uncertain outcomes, yet many remain unaware of these findings, leading to the misconception that surgery is the best or only solution.
When traditional treatments don’t provide relief, physicians may recommend steroid injections. However, research warns against this approach, as steroids can weaken tendon cells, worsen inflammation, break down cartilage, and increase the risk of fractures. While they may offer temporary symptom relief, they ultimately contribute to long-term damage.
A Regenerative Approach to Healing Golfer’s Elbow
For those seeking a safer, more effective alternative, regenerative medicine offers a promising solution. Studies have shown that stem cell therapy combined with platelet-rich plasma (PRP) injections can deliver significant long-term improvements for patients with golfer’s elbow. Unlike steroids, which degrade tissues over time, these biologic treatments work with your body’s natural healing processes to repair damaged tendons, reduce inflammation, and restore function.
At Rejuve, we specialize in cutting-edge regenerative therapies designed to treat the root cause of golfer’s elbow, providing lasting relief without the risks of surgery or steroids. If you’re ready to regain strength, mobility, and confidence in your arm, our innovative treatments can help you get back to doing what you love—without compromise.
-
“It doesn’t bother me to watch my legacy being upstaged by an operation that has saved plenty of ballplayers’ careers. What does bother me is that my name is now attached to something that affects more children than pro athletes. I was in my 30s and playing major league ball for nearly a dozen years before needing the operation. Today, 57 percent of all Tommy John surgeries are done on kids between 15 and 19 years old. One in 7 of those kids will never fully recover."
~ Tommy John
Understanding Tommy John Surgery: Risks, Alternatives, and Advanced Regenerative Solutions
Tommy John surgery, or ulnar collateral ligament (UCL) reconstruction, is a procedure traditionally performed on athletes, especially baseball pitchers, to repair a torn ligament in the elbow. However, this surgery has its limitations, with a lengthy recovery process and the risk of not fully returning to pre-injury performance levels. As a result, many athletes are now seeking alternatives to this invasive surgery.
The Limitations of Tommy John Surgery
While Tommy John surgery can be a necessary option for severe UCL injuries, it is highly invasive and comes with significant risks, including long recovery times and potential for further complications. Athletes undergoing the procedure face months of rehabilitation and uncertain outcomes, especially as they age. Recent research has shown that the success rate of Tommy John surgery is not as high as once thought, particularly for older athletes or those with previous elbow issues. The idea that surgery is the only option has become a misconception, especially with the availability of new, less invasive treatments.
Steroid Injections: A Short-Term Fix
When conservative treatments like rest and physical therapy fail, steroid injections are often considered as a next step. However, these injections can weaken the UCL and surrounding tissues, leading to further degeneration and a higher likelihood of re-injury. While steroids may provide short-term pain relief, they can worsen the underlying condition and delay the healing process in the long run.
A Regenerative Approach to Healing the UCL
For those looking to avoid the risks and long recovery times of surgery, regenerative medicine offers a promising alternative. Studies have shown that stem cell therapy combined with platelet-rich plasma (PRP) injections can provide long-term improvements for UCL injuries. These biologic treatments harness the body’s natural healing abilities to repair and regenerate the damaged ligament, reduce inflammation, and restore strength without the need for invasive surgery.
At Rejuve, we specialize in cutting-edge regenerative therapies designed to treat the root cause of UCL injuries, offering a safer, more effective option for athletes looking to return to their sport. Our advanced treatments can help you regain strength, mobility, and performance—without the risks and long recovery times of Tommy John surgery.
ELBOW JOINT HEALTH
The human body is designed to heal itself. Your body’s natural goal is repair and regeneration. A simple example is when you get a cut—your body stops the bleeding, forms a scab, and sends healing cells to close the wound.
This self-healing ability is constantly at work, even when you can’t see it. Your body is always scanning for damage and sending repair cells where they’re needed. However, certain factors influence how effectively your body can heal, including:
- Smoking habits
- Alcohol consumption
- Sleep quality and duration
- Regular physical activity
- Nutrition and digestion
- Stress management
Even with a healthy lifestyle—eating well, exercising, and getting enough rest—there are times when your body needs extra support. That’s where regenerative therapies at Rejuve Anti Aging can help. Our advanced treatments, including stem cell therapy and PRF, work with your body’s natural healing processes to restore function, reduce pain, and promote long-term wellness.
AND THAT’S WHERE REJUVE ANTI AGING CAN HELP!
REGENERATIVE MEDICINE AND ELBOW PAIN
Modern medicine often relies on medications that only mask pain rather than promoting true healing. Too many people are prescribed surgeries that may not effectively resolve their pain or the underlying problem.
Surgery itself is highly invasive—requiring tools that seem better suited for a construction site than the human body. That’s why it’s called surgical reconstruction. Recovery can take months or even years, and in many cases, the joint never fully feels or functions as it once did.
Joint replacement surgery introduces foreign materials into the body, which can create long-term issues. Just like your body reacts to a splinter—trying to push it out—your immune system may respond to implants with inflammation and pain, as it doesn’t recognize them as part of its natural structure.
At Rejuve Anti Aging, our regenerative therapies work with your body’s natural healing abilities. Using cutting-edge techniques, we concentrate and precisely deliver your body’s own regenerative cells to areas in need of repair, helping to restore function and reduce pain—without surgery. This approach, known as regenerative orthopedic medicine, has helped thousands regain mobility and live more active, pain-free lives.
100%
Saw improvement in pain scores in just 1 month!
120 participant results measured in 1-month follow ups following mesenchymal stem cell injections, compared to baseline.
Up to 76% Average Function Regained and Overall Pain Improvement
Frequently Asked Questions
Mesenchymal Stem Cells (MSCs) are undifferentiated cells capable of developing into diverse cell lineages. These cells maintain the capacity for self-renewal and are highly responsive to their surrounding environment. Upon receiving specific signals, they commit to differentiation pathways, transforming into specialized cells like skin, muscle, cartilage, tendon, bone, or red blood cells. Augmenting the availability of stem cells at a site of injury or damage can significantly promote optimal tissue regeneration by ensuring an ample supply of cells for repair.
Mesenchymal stem cells (MSCs) are increasingly utilized in treating a range of diseases due to their remarkable properties. These include self-renewal (the ability to create more stem cells), differentiation (the process of maturing into specialized cells with distinct form and function; for example, an MSC can develop into various cell types), anti-inflammatory effects (reducing harmful inflammation), and immunomodulation (regulating the immune system). Immunomodulation is particularly important, as MSCs can both stimulate a weak immune response and dampen an overactive one, potentially preventing the autoimmune reactions seen in many disorders. The anti-inflammatory capabilities of MSCs are crucial, as while inflammation is a natural defense mechanism, chronic or excessive inflammation can damage the body.
Extensive research, including both in-vitro (laboratory-based) and in-vivo (within a living organism) studies, has supported the safety and efficacy of MSC therapy and continues to elucidate the underlying mechanisms. This research highlights the diverse capabilities of MSCs, enabling their use in a variety of clinical settings for numerous degenerative conditions.
Emerging evidence suggests that umbilical cord tissue-derived MSCs (UC-MSCs) may possess greater potency compared to MSCs from other sources, potentially leading to enhanced clinical effectiveness.
Adult mesenchymal stem cells (MSCs) do not raise the same ethical concerns as fetal and embryonic stem cells. Both the Catholic Church and the Southern Baptist Convention have endorsed the research and therapeutic use of adult stem cells as an ethically acceptable alternative.
Advantages of Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (UC-MSCs)
Umbilical cord tissue-derived mesenchymal stem cells (UC-MSCs) offer several advantages over other sources of MSCs, such as bone marrow-derived MSCs (BM-MSCs) and adipose-derived stem cells (ASCs):
Superior Proliferation: UC-MSCs exhibit a significantly higher proliferation rate in vitro (in a laboratory setting) compared to BM-MSCs and ASCs. This allows for more efficient expansion to obtain the large cell numbers needed for therapeutic applications.
Non-Invasive Harvesting: The collection of UC-MSCs is non-invasive. The cells are obtained from ethically donated umbilical cord tissue after birth, a process that poses no risk or discomfort to either the mother or the newborn. This contrasts with BM-MSC harvesting, which requires a bone marrow aspiration, and ASC harvesting, which typically involves liposuction.
Enhanced Secretion of Beneficial Factors: UC-MSCs secrete a variety of growth factors, cytokines, and chemokines. These secreted factors play a crucial role in tissue repair, reducing inflammation, and modulating the immune system.
Differentiation Potential: Like other MSCs, UC-MSCs can differentiate into various cell types, contributing to tissue regeneration.
Upregulated Genes: Research indicates that certain genes associated with cell proliferation (e.g., EGF), signaling pathways involved in cell survival and growth (e.g., PI3K-NFkB pathway via TEK), and neurogenesis (e.g., RTN1, NPPB, NRP2) are upregulated (have increased activity) in UC-MSCs compared to BM-MSCs. This suggests a potentially greater capacity for tissue repair and regeneration.
Yes! In recent years, several regenerative medicine treatments have been introduced into clinical practice for pain management and orthopedic care. These treatments utilize adult stem cells, making them non-controversial. The available procedures include:
- Platelet-Rich Plasma (PRP) Therapy
- Mesenchymal Stem Cell-Rich Injections
- Bone Marrow-Derived Stem Cell Injections
- Fat-Derived Stem Cell Injections
Regenerative medicine may offer benefits for various medical conditions, including:
- Joint arthritis
- Tennis elbow (lateral epicondylitis)
- Golfer’s elbow (medial epicondylitis)
- Rotator cuff tendonitis
- Ligament sprains
- Fractures
- Tendon injuries
- Cartilage defects
- COPD
- Kidney failure
- Stroke
- Multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS)
- Dementia
- Erectile dysfunction
- Heart failure
- Diabetes
- Diabetic neuropathy
MSCs possess immunosuppressive properties, reducing the likelihood of immune rejection compared to other foreign cells. Umbilical cord tissue-derived MSCs (UC-MSCs) are particularly immune-privileged, meaning they are universally accepted by the recipient’s body with virtually no risk of rejection. This is because UC-MSCs are essentially “new” and haven’t been “claimed” by a specific immune system. Unlike organ transplantation, UC-MSC therapy doesn’t require blood products or HLA matching.
Regenerative medicine procedures are generally not covered by insurance. While some surgical applications may have billing codes, most treatments are considered out-of-pocket expenses.
The price range for regenerative medicine injections is broad, typically between $1,500 and $7,500.
Our protocol is designed to significantly reduce chronic low-grade inflammation over an extended period. Stem cells possess a unique ability to target areas of inflammation in the body. Research indicates that they can regenerate damaged or diseased tissues, decrease inflammation, and regulate the immune system—contributing to improved health and overall quality of life.
Studies suggest that mesenchymal stem cells (MSCs) may have a positive impact on various conditions, including:
- ALS
- Alzheimer’s disease
- Autoimmune disorders
- COPD and other degenerative/inflammatory lung diseases
- COVID-19 (acute and long-haul)
- Chronic inflammation
- Crohn’s disease
- Type 1 diabetes
- Heart failure and heart disease
- Kidney disease
- Liver disease
- Lupus
- Lyme disease
- Multiple sclerosis
- Degenerative neurological conditions
- Neuropathy
- Parkinson’s disease
- Reflex Sympathetic Dystrophy (RSD) / Complex Regional Pain Syndrome (CRPS)
- Rheumatoid arthritis
- Spinal cord injuries
- Stroke (ischemic and hemiplegic)
- Traumatic brain injury (TBI)
Our protocol aims for long-term stabilization of the condition with a single treatment. Follow-up treatments are not required. While some patients choose to return for additional treatments, typically seeking further improvement, generally one treatment is sufficient for most degenerative conditions.
Patients generally report minimal discomfort during treatment, often describing the experience as painless.
While individual responses vary, many study participants report noticeable improvements within 1-3 months after treatment. These improvements are evidenced by reduced systemic inflammation and increased vitality, as measured by follow-up questionnaires. Some patients report improvements in symptoms and quality of life even sooner, within the first few days post-treatment.
Umbilical cord-derived mesenchymal stem cells (UC-MSCs) are particularly effective for systemic delivery via intravenous infusion. Their optimal size (17-19 micrometers) allows for efficient passage through the circulatory system, including the lungs. Although a portion of MSCs may initially be trapped in the lungs (a phenomenon known as the pulmonary first-pass effect), this does not negate their therapeutic benefits. MSCs possess a remarkable homing ability – they can actively migrate to damaged tissues. Even while temporarily in the lungs, MSCs exert beneficial paracrine effects: they secrete growth factors and other molecules that reduce inflammation and stimulate tissue repair. Advances in research are continually enhancing the delivery and efficacy of MSCs for regenerative therapies.
Potential of Stem Cells in Anti-Aging and Rejuvenation
Current research suggests that stem cell therapies may have the potential to mitigate some effects of aging and improve overall healthspan. Stem cells, particularly mesenchymal stem cells (MSCs), possess properties that could contribute to this, including their ability to:
- Repair damaged tissues: Stem cells can differentiate into various cell types, potentially replacing aged or damaged cells.
- Reduce inflammation: Chronic inflammation is a key contributor to age-related decline, and MSCs have anti-inflammatory effects.
- Modulate the immune system: MSCs can help regulate immune function, which often declines with age.
- Homing Capability: Stem cells can migrate to sites of damage or inflammation.
The concept of a “protective shield” created by stem cells and anti-aging genes is a simplified representation of these complex biological processes. While a complete reversal of aging is not currently feasible, studies suggest that stem cell interventions, potentially in combination with therapies targeting aging-related genes, could contribute to a healthier and potentially longer lifespan. It’s crucial to understand that this is an area of ongoing research, and many claims about “anti-aging” stem cell treatments are not yet supported by robust clinical evidence.
Potential Benefits of Stem Cell Therapy (Observed and Reported):
Some reported benefits of stem cell therapies, particularly in the context of age-related decline, include:
- Increased energy and vitality
- Improved physical capacity and endurance
- Improved hair quality and thickness
- Enhanced libido
- Pain reduction
- Increased strength, balance, and overall mobility
- Enhanced immune function
- Overall improvement in quality of life
- Reduced inflammatory markers
Mesenchymal stem cells (MSCs) are not a cause of graft-versus-host disease (GVHD); in fact, they are being investigated as a potential treatment for this condition. GVHD is a serious complication that can occur after allogeneic hematopoietic stem cell transplantation (typically bone marrow or cord blood transplants), where the donor’s immune cells (T-cells) attack the recipient’s tissues.
MSCs possess immunomodulatory properties that make them promising candidates for GVHD therapy. They achieve this through several mechanisms, including:
- Secretion of bioactive molecules: MSCs release proteins, peptides, and hormones that can suppress the immune response.
- Mitochondrial transfer: MSCs can transfer mitochondria (the energy-producing components of cells) to damaged cells, potentially aiding in tissue repair.
- Exosome and microvesicle release: MSCs release small vesicles containing RNA and other molecules that can influence the behavior of recipient cells, including immune cells.
While many studies suggest that MSC therapy can be beneficial for both acute and chronic GVHD, more extensive, large-scale, randomized controlled trials are needed to definitively confirm these findings and establish optimal treatment protocols.
It is important to clarify a distinction: although MSCs can modulate the activity of immune cells like T-lymphocytes and B-lymphocytes (reducing their proliferation and secretion of inflammatory factors), they are not broadly immunosuppressive in the same way as traditional immunosuppressant drugs. They have targeted immunomodulatory effects, rather than causing widespread immune suppression. This targeted effect is one reason they are promising for treating GVHD.
Follow-up vitality questionnaires indicate that approximately 85% of patients report sustained improvement in their condition within three months of treatment.